1. Biochemistry and Chemical Biology
  2. Microbiology and Infectious Disease

Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide

  1. Dominik Witzigmann  Is a corresponding author
  2. Philipp Uhl
  3. Sandro Sieber
  4. Christina Kaufman
  5. Tomaz Einfalt
  6. Katrin Schöneweis
  7. Philip Grossen
  8. Jonas Buck
  9. Yi Ni
  10. Susanne H Schenk
  11. Janine Hussner
  12. Henriette E Meyer zu Schwabedissen
  13. Gabriela Québatte
  14. Walter Mier
  15. Stephan Urban
  16. Jörg Huwyler  Is a corresponding author
  1. University of Basel, Switzerland
  2. University Hospital Heidelberg, Germany
https://doi.org/10.7554/eLife.42276
Share this article
Cite this article
  1. Dominik Witzigmann
  2. Philipp Uhl
  3. Sandro Sieber
  4. Christina Kaufman
  5. Tomaz Einfalt
  6. Katrin Schöneweis
  7. Philip Grossen
  8. Jonas Buck
  9. Yi Ni
  10. Susanne H Schenk
  11. Janine Hussner
  12. Henriette E Meyer zu Schwabedissen
  13. Gabriela Québatte
  14. Walter Mier
  15. Stephan Urban
  16. Jörg Huwyler
(2019)
Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide
eLife 8:e42276.
https://doi.org/10.7554/eLife.42276
  2. Download BibTeX
  3. Download .RIS

Abstract

Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here, we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the sodium-taurocholate cotransporting polypeptide (NTCP; SLC10A1) on the sinusoidal membrane of hepatocytes. Physicochemical properties of targeted nanoparticles were optimized and NTCP-specific, ligand-dependent binding and internalization was confirmed in vitro. The pharmacokinetics and targeting capacity of selected lead formulations was investigated in vivo using the emerging zebrafish screening model. Liposomal nanoparticles modified with 0.25 mol% of a short myristoylated HBV derived peptide, i.e. Myr‑HBVpreS2-31, showed an optimal balance between systemic circulation, avoidance of blood clearance, and targeting capacity. Pronounced liver enrichment, active NTCP‑mediated targeting of hepatocytes and efficient cellular internalization were confirmed in mice by 111In gamma scintigraphy and fluorescence microscopy demonstrating the potential use of our hepatotropic, ligand-modified nanoparticles.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Numerical data for all quantitative graphs are provided in the Figure source data.

Article and author information

Author details

  1. Dominik Witzigmann

    Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    For correspondence
    dominik.witzigmann@unibas.ch
    Competing interests
    The authors declare that no competing interests exist.

  2. Philipp Uhl

    Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.

  3. Sandro Sieber

    Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.

  4. Christina Kaufman

    Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.

  5. Tomaz Einfalt

    Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.

  6. Katrin Schöneweis

    Department of Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.

  7. Philip Grossen

    Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3416-5570

  8. Jonas Buck

    Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.

  9. Yi Ni

    Department of Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.

  10. Susanne H Schenk

    Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.

  11. Janine Hussner

    Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.

  12. Henriette E Meyer zu Schwabedissen

    Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0458-4579

  13. Gabriela Québatte

    Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.

  14. Walter Mier

    Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.

  15. Stephan Urban

    Department of Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.

  16. Jörg Huwyler

    Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
    For correspondence
    joerg.huwyler@unibas.ch
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1748-5676

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (174975)

  • Dominik Witzigmann

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (173057)

  • Jonas Buck
  • Jörg Huwyler

Deutsche Forschungsgemeinschaft (209091148)

  • Stephan Urban

Deutsches Zentrum für Infektionsforschung (5.704)

  • Stephan Urban

Deutsches Zentrum für Infektionsforschung (5.807)

  • Stephan Urban

Freiwillige Akademische Gesellschaft (FAG Basel)

  • Dominik Witzigmann
  • Sandro Sieber
  • Jörg Huwyler

Stiftung zur Förderung des pharmazeutischen Nachwuchses in Basel

  • Sandro Sieber

Novartis University Basel Excellence SCholarship for Life Sciences

  • Dominik Witzigmann

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal experimentation: Zebrafish embryo (Danio rerio) studies were performed in strict accordance with Swiss animal welfare regulations. Mouse and rat experiments were carried out in accordance with German legislation on animal welfare. All of the animals were handled according to approved institutional animal care and use protocol of the University of Basel and University of Heidelberg.

Copyright

© 2019, Witzigmann et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,627
    views
  • 452
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Dominik Witzigmann
  2. Philipp Uhl
  3. Sandro Sieber
  4. Christina Kaufman
  5. Tomaz Einfalt
  6. Katrin Schöneweis
  7. Philip Grossen
  8. Jonas Buck
  9. Yi Ni
  10. Susanne H Schenk
  11. Janine Hussner
  12. Henriette E Meyer zu Schwabedissen
  13. Gabriela Québatte
  14. Walter Mier
  15. Stephan Urban
  16. Jörg Huwyler
(2019)
Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide
eLife 8:e42276.
https://doi.org/10.7554/eLife.42276

Share this article

https://doi.org/10.7554/eLife.42276

Categories and tags

Research organisms

Further reading

    1. Biochemistry and Chemical Biology

    Disordered proteins interact with the chemical environment to tune their protective function during drying

    Shraddha KC, Kenny H Nguyen ... Thomas C Boothby
    Research Article

    The conformational ensemble and function of intrinsically disordered proteins (IDPs) are sensitive to their solution environment. The inherent malleability of disordered proteins, combined with the exposure of their residues, accounts for this sensitivity. One context in which IDPs play important roles that are concomitant with massive changes to the intracellular environment is during desiccation (extreme drying). The ability of organisms to survive desiccation has long been linked to the accumulation of high levels of cosolutes such as trehalose or sucrose as well as the enrichment of IDPs, such as late embryogenesis abundant (LEA) proteins or cytoplasmic abundant heat-soluble (CAHS) proteins. Despite knowing that IDPs play important roles and are co-enriched alongside endogenous, species-specific cosolutes during desiccation, little is known mechanistically about how IDP-cosolute interactions influence desiccation tolerance. Here, we test the notion that the protective function of desiccation-related IDPs is enhanced through conformational changes induced by endogenous cosolutes. We find that desiccation-related IDPs derived from four different organisms spanning two LEA protein families and the CAHS protein family synergize best with endogenous cosolutes during drying to promote desiccation protection. Yet the structural parameters of protective IDPs do not correlate with synergy for either CAHS or LEA proteins. We further demonstrate that for CAHS, but not LEA proteins, synergy is related to self-assembly and the formation of a gel. Our results suggest that functional synergy between IDPs and endogenous cosolutes is a convergent desiccation protection strategy seen among different IDP families and organisms, yet the mechanisms underlying this synergy differ between IDP families.

    1. Biochemistry and Chemical Biology
    2. Stem Cells and Regenerative Medicine

    Proteomic and functional comparison between human induced and embryonic stem cells

    Alejandro J Brenes, Eva Griesser ... Angus I Lamond
    Research Article

    Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics

    Isobaric crosslinking mass spectrometry technology for studying conformational and structural changes in proteins and complexes

    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.